Willuth, E.
Hardon, S. F.
Lang, F.
Haney, C. M.
Felinska, E. A.
Kowalewski, K. F.
Müller-Stich, B. P.
Horeman, T.
Nickel, F. http://orcid.org/0000-0001-6066-8238
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 22 November 2020
Accepted: 9 February 2021
First Online: 26 February 2021
Compliance with ethical standards
:
: Estelle Willuth, Sem Hardon, Franziska Lang, Caelan M. Haney, Eleni A. Felinska, and Beat-Peter Müller-Stich have no conflicts of interest or financial ties to disclose. Felix Nickel reports receiving travel support for conference participation as well as equipment provided for laparoscopic surgery courses by KARL STORZ, Johnson & Johnson, Intuitive Surgical, Cambridge Medical Robotics, and Medtronic and he reports consultancy fees from KARL STORZ. Karl-Friedrich Kowalewski received travel and non-financial support from Intuitive Surgical and Cambridge Medical Robotics. Tim Horeman is founder and shareholder of the TU-Delft MedTech startup Medishield Delft BV.